AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
4 min read In This Article ATRC Revenue: $465 million for 2024, a 17% growth. Adjusted EBITDA: Increased from $19 million in 2023 to $31 million in 2024. Fourth Quarter Revenue: $124.3 million, a 16.6% increase from Q4 2023. US Revenue: $101.6 million in Q4 2024, a 14.4% increase from Q4 2023. International Revenue: $22.7 million in Q4 2024, up 27.7% from Q4 2023. Gross Margin: 74.5% in Q4 2024, a decrease of 39 basis points from Q4 2023. Research and Development Expenses: Increased by 68.1% in Q4 2024. SG&A Expenses: Increased by 6.6% in Q4 2024. Adjusted Loss Per Share: $0.08 in Q4 2024, compared to $0.21 in Q4 2023. Full Year US Sales: $382.8 million, a 14.8% increase. Full Year International Sales: $82.5 million, a 25.6% increase. Cash and Investments: $122.7 million at the end of 2024. 2025 Revenue Guidance: $517 million to $527 million. 2025 Adjusted EBITDA Guidance: $42 million to $44 million. Warning! GuruFocus has detected 3 Warning Sign wit
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.MarketBeat
- AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human Success - Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- AtriCure Announces the First Patients Treated with Novel Dual Energy PlatformBusiness Wire
- Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- AtriCure (ATRC): Exploring Valuation After Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
ATRC
Earnings
- 10/29/25 - Beat
ATRC
Sec Filings
- 12/12/25 - Form 4
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- ATRC's page on the SEC website